1.6894
-0.0406 (-2.35%)
-0.0406 (-2.35%)
Upgrade to Real-Time
Regular Market
| Volume | 14,014 |
|
|||||
| News | - | ||||||
| Day High | 1.7399 | Low High |
|||||
| Day Low | 1.66 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regulus Therapeutics Inc | RGLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0406 | -2.35% | 1.6894 | 10:20:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.70 | 1.66 | 1.7399 | 1.73 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 41 | 14,014 | $ 1.68 | $ 23,611 | - | 0.1576 - 2.4399 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:18:27 | 140 | $ 1.6894 | USD |
Period:
Draw Mode:
Regulus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 24.72M | 14.63M | 11.11M | $ - | $ - | -3.18 | -0.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.23M | 41.00% |
Regulus Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.69 | 1.8399 | 1.64 | 1.75 | 113,414 | -0.0006 | -0.04% |
| 1 Month | 1.88 | 1.96 | 1.42 | 1.69 | 141,554 | -0.1906 | -10.14% |
| 3 Months | 0.2877 | 2.4399 | 0.2012 | 0.5103399 | 471,068 | 1.40 | 487.21% |
| 6 Months | 0.22 | 2.4399 | 0.1576 | 0.2992018 | 1,374,423 | 1.47 | 667.91% |
| 1 Year | 0.66 | 2.4399 | 0.1576 | 0.3809355 | 1,475,529 | 1.03 | 155.97% |
| 3 Years | 0.5677 | 2.4399 | 0.1576 | 0.8784385 | 1,504,036 | 1.12 | 197.59% |
| 5 Years | 9.96 | 18.24 | 0.1576 | 2.02 | 1,130,839 | -8.27 | -83.04% |
Regulus Therapeutics Description
| Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. |